Absci Corporation Common Stock
$9.65
$0.38 (+4.10%)
$9.08Day Range$9.74
Key Statistics
Market Cap
$1.59B
Shares Outstanding
171.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 22, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$9.27
Day High
$9.74
Day Low
$9.08
Volume
7.73M
VWAP
$9.56
Prev Close
$9.27
Transactions
--
Acc. Volume
--
About Absci Corporation Common Stock
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHSIC 8731140 employees18105 SE MILL PLAIN BLVD, VANCOUVER, WA, 98683(360) 949-1041IPO Jul 22, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001672688
- Composite FIGI
- BBG011N54CJ8
- Share Class FIGI
- BBG011N54DC3
- Ticker Root
- ABSI
- SIC Code
- 8731
About Absci Corporation Common Stock (ABSI) Stock
Absci Corporation Common Stock (ABSI) closed the 2026-09-18 session at $9.65, up 4.10% versus the previous close (+0.38). The stock opened at $9.27 and traded between $9.08 and $9.74 during that session. Session trading volume was 7.7M shares. The volume-weighted average price (VWAP) is $9.56.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Absci Corporation Common Stock has a market capitalization of $1.59 billion. The company operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry classification. ABSI is listed on the XNAS exchange. The company employs approximately 140 people. Absci Corporation Common Stock is headquartered in VANCOUVER, WA. The recorded listing date is 2021-07-22.
On this page you can find market ABSI stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector.